Suchergebnisse - "Itolizumab"

PubPharm (6)

1

A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19

enthalten in: Expert opinion on biological therapy | 2021

von Kumar, S. | De Souza, R. | Nadkar, M. | +7

2

Anti-CD6 mAbs for the treatment of psoriasis

enthalten in: Expert opinion on biological therapy | 2020

von Dogra, S. | D, S. | Rajagopalan, M.

3

Itolizumab, an anti-CD6 monoclonal antibody, as a potential treatment for COVID-19 complications

enthalten in: Expert opinion on biological therapy | 2020

von Loganathan, S. | Athalye, S. | Joshi, S.

4

Use of a Humanized Anti-CD6 Monoclonal Antibody (Itolizumab) in Elderly Patients with Moderate COVID-19

enthalten in: Gerontology | 2020

von Díaz, Y. | Ramos-Suzarte, M. | Martín, Y. | +17

5

Itolizumab, a novel anti-CD6 monoclonal antibody : a safe and efficacious biologic agent for management of psoriasis

enthalten in: Expert opinion on biological therapy | 2017

von Dogra, S. | Uprety, S. | Suresh, S.

6

Itolizumab in combination with methotrexate modulates active rheumatoid arthritis : safety and efficacy from a phase 2, randomized, open-label, parallel-group, dose-ranging study

enthalten in: Clinical rheumatology | 2016

von Chopra, A. | Chandrashekara, S. | Iyer, R. | +10

1
[1]